Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 254.40M | 271.69M | 256.89M | 246.21M | 240.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 254.40M | 271.69M | 256.89M | 246.21M | 240.37M |
| Cost of Revenue | 175.79M | 188.14M | 179.00M | 170.65M | 166.34M |
| Gross Profit | 78.61M | 83.55M | 77.89M | 75.56M | 74.03M |
| SG&A Expenses | 66.06M | 69.80M | 64.66M | 64.33M | 62.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -424.80K | -17.60K | 144.40K | 60.40K | -1.37M |
| Total Operating Expenses | 241.43M | 257.92M | 243.80M | 235.04M | 227.91M |
| Operating Income | 12.97M | 13.77M | 13.08M | 11.17M | 12.46M |
| Income Before Tax | 5.87M | 6.90M | 6.47M | 5.16M | 5.94M |
| Income Tax Expenses | 1.97M | 3.49M | 3.16M | 2.31M | 785.40K |
| Earnings from Continuing Operations | 3.91M | 3.41M | 3.31M | 2.85M | 5.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.91M | 3.41M | 3.31M | 2.85M | 5.15M |
| EBIT | 12.97M | 13.77M | 13.08M | 11.17M | 12.46M |
| EBITDA | 30.51M | 27.41M | 26.23M | 25.62M | 27.39M |
| EPS Basic | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 408.84M | 408.84M | 408.84M | 408.84M | 408.85M |
| Average Diluted Shares Outstanding | 408.84M | 408.84M | 408.84M | 408.84M | 408.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
